Related content

Imatinib mesylate inhibits FAK signaling in medullary thyroid carcinoma cells

By Kim L.T.   Teng K.   Nwariaku F.  

Journal of Surgical Research, Vol. 114, Iss. 2, 2003-10 ,pp. : 270-271

Elsevier

Access to resources Recommend Favorite

Treatment of collagen-induced arthritis with recombinant plasminogen-related protein B: a novel inhibitor of angiogenesis

By Tanaka Koichiro   Morii Takeshi   Weissbach Lawrence   Horiuchi Keisuke   Takeuchi Katsuhito   Toyama Yoshiaki   Morioka Hideo  

Journal of Orthopaedic Science, Vol. 16, Iss. 4, 2011-07 ,pp. : 443-450

Springer Publishing Company

Access to resources Recommend Favorite

Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate

By Yang Kyu-Hyun  

Journal of Bone and Mineral Metabolism, Vol. 28, Iss. 6, 2010-11 ,pp. : 713-718

Springer Publishing Company

Access to resources Recommend Favorite

Giant Gastrointestinal Stromal Tumor with Remarkable Preoperative Response to Imatinib Mesylate

By Stokes Allen   Herndon Mark D.   Conforti Arnold M.  

The American Surgeon, Vol. 76, Iss. 8, 2010-08 ,pp. : 903-904

Southeastern Surgical Congress

Access to resources Recommend Favorite

Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case

By Ando Koji  

Surgery Today, Vol. 41, Iss. 9, 2011-09 ,pp. : 1290-1293

Springer Publishing Company

Access to resources Recommend Favorite